Tekla Capital Management LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$901,000
+14.8%
66,6880.0%0.03%
+10.3%
Q3 2020$785,000
-20.2%
66,6880.0%0.03%
-21.6%
Q2 2020$984,000
+9.3%
66,6880.0%0.04%
-9.8%
Q1 2020$900,000
-44.2%
66,6880.0%0.04%
-32.8%
Q4 2019$1,612,000
+25.7%
66,6880.0%0.06%
+8.9%
Q3 2019$1,282,000
-35.0%
66,6880.0%0.06%
-30.0%
Q2 2019$1,971,000
-39.4%
66,688
-2.6%
0.08%
-39.4%
Q1 2019$3,254,000
+132.4%
68,496
+76.7%
0.13%
+120.0%
Q4 2018$1,400,000
-41.3%
38,7700.0%0.06%
-31.0%
Q3 2018$2,386,00038,7700.09%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders